History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In 1876, von Kupffer described liver Sternzellen (star-shaped cells). The functions of these cells remained enigmatic for 75 years until Ito observed lipid-containing perisinusoidal cells in human liver. In 1971, Wake demonstrated that the Sternzellen of von Kupffer and the fat-storing cells described by Ito were identical. Wake also established that these cells were important sites of vitamin A storage. Soon thereafter, Kent and Popper demonstrated that the stellate cells were intimately linked to the pathogenesis of hepatic fibrosis. Since then, these cells have been studied in detail. Quiescent stellate cells represent 5-8% of the total number of liver cells. They play a cardinal role in storage and controlled release of retinoids. They control extracellular matrix (ECM) turnover in the space of Disse by secreting the correct amounts of a limited number of ECM molecules, and by releasing matrix metalloproteinases and their inhibitors. By virtue of their long cytoplasmic processes, quiescent stellate cells presumably contribute to the control of blood flow through the sinusoidal capillaries. They are important sources of paracrine, autocrine, juxtacrine, and chemoattractant factors that maintain homeostasis in the microenvironment of the hepatic sinusoid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the healthy liver, HSCs are in a quiescent state (qHSCs), in which they store large amounts of retinoids in the form of retinyl esters [16, 221].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [16]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Items 201–300 of 734
Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction–Associated Steatohepatitis
Kisseleva, T., Ganguly, S., Murad, R., Wang, A., & Brenner, D. A. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.010 · Cited by 86
Innervation of the sinusoidal wall: Regulation of the sinusoidal diameter
Ueno, T., Bioulac‐Sage, P., Balabaud, C., & Rosenbaum, J. (2004) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.20092 · Cited by 64
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Vitamin A Deficiency and Alterations in the Extracellular Matrix
Barber, T., Esteban-Pretel, G., Marín, M., & Timoneda, J. (2014) · Nutrients · doi:10.3390/nu6114984 · Cited by 63
New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article
Ebrahimi, H., Naderian, M., & Sohrabpour, A. A. (2016) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2016.29 · Cited by 70
Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine
Gordillo‐Bastidas, D., Oceguera-Contreras, E., Salazar-Montes, A., González-Cuevas, J., Hernández-Ortega, L. D., & Armendáriz-Borunda, J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i47.9020 · Cited by 66
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
Relationships Among Stellate Cell Activation, Progenitor Cells, and Hepatic Regeneration
Roskams, T. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.014 · Cited by 64
Role of cannabinoids in chronic liver diseases
Parfieniuk‐Kowerda, A., & Flisiak, R. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6109 · Cited by 61
Engineering in vitro models of hepatofibrogenesis
Mazza, G., Al‐Akkad, W., & Rombouts, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.018 · Cited by 65
Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts
Lepreux, S., & Desmoulière, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00173 · Cited by 58
Martins, L. A. M., Vieira, M. Q., Ilha, M., de Vasconcelos, M., Biehl, H. B., de Lima, D. B., Schein, V., Barbé‐Tuana, F. M., Borojević, R., & Guma, F. T. C. R. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0245-5 · Cited by 68
Baade, S., Aupperle, H., Grevel, V., & Schoon, H.-A. (2006) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2005.07.003 · Cited by 57
Epigenetic cell fate regulation of hepatic stellate cells
Tsukamoto, H., Zhu, N., Asahina, K., Mann, D. A., & Mann, J. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00804.x · Cited by 57
Involvement of integrin-linked kinase in carbon tetrachloride–induced hepatic fibrosis in rats
Zhang, Y., Ikegami, T., Honda, A., Miyazaki, T., Bouscarel, B., Rojkind, M., Hyodo, I., & Matsuzaki, Y. (2006) · Hepatology · doi:10.1002/hep.21315 · Cited by 57
Hepatic stellate cell progenitor cells
Asahina, K. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07001.x · Cited by 58
Greupink, R., Bakker, H. I., Bouma, W., Reker‐Smit, C., Meijer, D. K. F., Beljaars, L., & Poelstra, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099499 · Cited by 62
Hepatic stellate cells, liver innate immunity, and hepatitis C virus
Wang, Y., Li, J., Wang, X., Sang, M., & Ho, W. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12023 · Cited by 67
Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats
Shin, D.-S., Kim, K. W., Chung, H. Y., Yoon, S., & Moon, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0033-6 · Cited by 58
Gliotoxin Ameliorates Development of Fibrosis and Cirrhosis in a Thioacetamide Rat Model
Dekel, R., Zvibel, I., Brill, S., Brazovsky, E., Halpern, Z., & Oren, R. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024792529601 · Cited by 57
Yan, Z., Qu, K., Zhang, J., Huang, Q., Qu, P., Xu, X., Yuan, P., Huang, X., Shao, Y., Liu, C., et al. (2015) · Clinical Science · doi:10.1042/cs20140823 · Cited by 55
Zhu, N., Wang, J., & Tsukamoto, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156703 · Cited by 55
Vitamin A and insulin are required for the maintenance of hepatic stellate cell quiescence
Yoneda, A., Sakai, K., Niitsu, Y., & Tamura, Y. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.012 · Cited by 63
Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis
Melton, A. C., & Yee, H. F. (2007) · Hepatology · doi:10.1002/hep.21606 · Cited by 55
Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure
Yan, C., Zhou, L., & Han, Y. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01775.x · Cited by 54
Estep, M., Baranova, A. V., Hossain, N., Elariny, H. A., Ankrah, K., Afendy, A., Chandhoke, V., & Younossi, Z. M. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9814-x · Cited by 56
Nguyen, G., Park, S. Y., Le, C. T., Park, W. S., Choi, D. H., & Cho, E.-H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.143 · Cited by 58
Recent advances in the pathogenesis and diagnosis of liver fibrosis
Torok, N. J. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2181-x · Cited by 61
Mao-chuan, Z. H. E. N., Huang, X., Wang, Q., Kai, S. U. N., Yun-jian, L. I. U., Wen, L. I., Zhang, L., Cao, L., & Xi-ling, C. H. E. N. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00439.x · Cited by 61
Monitoring fibrogenic progression in the liver
Gressner, O. A., & Gao, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.02.021 · Cited by 55
The role of the miR-31 /FIH1 pathway in TGF-β-induced liver fibrosis
Hu, J., Chen, C., Liu, Q., Liu, B., Song, C., Zhu, S., Wu, C., Liu, S., Yu, H., Yao, D., et al. (2015) · Clinical Science · doi:10.1042/cs20140012 · Cited by 58
Effect of celecoxib on experimental liver fibrosis in rat
Hui, A., Leung, W. K., Chan, H. L., Chan, F. K. L., Go, M. Y. Y., Chan, K. K., Tang, B., Chu, E. S., & Sung, J. J. �. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01202.x · Cited by 52
Jang, Y. O., Jun, B. G., Baik, S. K., Kim, M. Y., & Kwon, S. O. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.2.141 · Cited by 52
Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair
Schachtrup, K., Moan, N. L., Passino, M. A., & Akassoglou, K. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15828 · Cited by 54
Schaefer, B., Rivas, A., Meraz‐Cruz, N., Reyes-Romero, M. A., Nazará, Z., Domínguez-Rosales, J. A., Schuppan, D., Greenwel, P., & Rojkind, M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64312-x · Cited by 59
Adrian, J. E., Poelstra, K., Scherphof, G. L., Molema, G., Meijer, D. K. F., Reker‐Smit, C., Morselt, H. W. M., & Kamps, J. A. A. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.027 · Cited by 52
Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells
Zhao, Z., Li, Y., Jain, A., Chen, Z., Liu, H., Jin, W., & Cheng, K. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.08.017 · Cited by 49
Venkatesh, S. K., & Torbenson, M. S. (2022) · Abdominal Radiology · doi:10.1007/s00261-021-03396-y · Cited by 56
Regulation of Sinusoidal Perfusion in Portal Hypertension
Reynaert, H., Urbain, D., & Geerts, A. E. (2008) · The Anatomical Record · doi:10.1002/ar.20669 · Cited by 50
Self-citationLiver Fibrosis and Chronic Viral Hepatitis
Gutiérrez‐Reyes, G., Gutiérrez‐Ruíz, M. C., & Kershenobich, D. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.001 · Cited by 55
Identification of markers for quiescent pancreatic stellate cells in the normal human pancreas
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1581-5 · Cited by 53
Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia
Ribera, J., Vilches, C., Sanz, V., de Miguel, I., Portolés, I., Córdoba‐Jover, B., Prat, E., Nunes, V., Jiménez, W., Quidant, R., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00988 · Cited by 52
Xia, Y., Zhen, L., Li, H., Wang, S., Sun, C., Wang, C., & Yang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03494-1 · Cited by 51
Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
Petrescu, A. D., & DeMorrow, S. (2021) · Cells · doi:10.3390/cells10081846 · Cited by 50
Chen, R., Li, Q., Xu, S., Ye, C., Tian, T., Jiang, Q., Shan, J., & Ruan, J. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02435-4 · Cited by 57
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis
Xi, Y., LaCanna, R., N’Diaye, E.-N., Gierke, S., Ma, H., Caplazi, P., Sagolla, M. S., Huang, Z., Lucio, L., Arlantico, A., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.009 · Cited by 51
Role of the receptor for advanced glycation end products inhepatic fbrosis
Lohwasser, C., Neureiter, D., Popov, Y. V., Bauer, M. W., & Schuppan, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5789 · Cited by 53
Xu, T., Ni, M.-M., Xingli, Li, X., Meng, X., Huang, C., & Li, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.010 · Cited by 54
Jameel, N. M., Thirunavukkarasu, C., Wu, T., Watkins, S. C., Friedman, S. L., & Gandhi, C. R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21581 · Cited by 49
March, S., Graupera, M., Sarrias, M., Lozano, F., Pizcueta, P. M., Bosch, J., & Engel, P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.051212 · Cited by 53
van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.019 · Cited by 53
Asai, K., Tamakawa, S., Yamamoto, M., Yoshie, M., Tokusashi, Y., Yaginuma, Y., Kasai, S., & Ogawa, K. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01267.x · Cited by 48
Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells
Lim, Y., Lee, H.-C., & Lee, H.-S. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0233-y · Cited by 48
Targeted Delivery of a Triplex-Forming Oligonucleotide to Hepatic Stellate Cells
Ye, Z., Cheng, K., Guntaka, R. V., & Mahato, R. I. (2005) · Biochemistry · doi:10.1021/bi047529j · Cited by 49
Fibrogenic cell reversion underlies fibrosis regression in liver
Friedman, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206645109 · Cited by 48
Jin, Y., Bai, Y., Ni, H., Li, Q., Ye, L., Shan, Y., & Zhou, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12090 · Cited by 50
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Muddu, A. K., Guha, I. N., Elsharkawy, A. M., & Mann, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.006 · Cited by 55
Miele, L., Forgione, A., Torre, G. L., Vero, V., Cefalo, C., Racco, S., Vellone, V. G., Vecchio, F. M., Gasbarrini, A., Rapaccini, G. L., et al. (2009) · Translational research · doi:10.1016/j.trsl.2009.06.007 · Cited by 46
Kang, N., Shah, V. H., & Urrutia, R. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0542 · Cited by 46
Trinh, V. Q.-H., Lee, T.-F., Lemoinne, S., Ray, K. C., Ybanez, M. D., Tsuchida, T., Carter, J. K., Agudo, J., Brown, B. D., Akat, K. M., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adf6696 · Cited by 45
“To reconstitute liver mass, activated HSCs synthesize the complex hepatic extracellular matrix (ECM) (27), promote angiogenesis (28), and induce hepatocyte proliferation (16).”
BackgroundInflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 53
Noninvasive Tools to Assess Hepatic Fibrosis: Ready for Prime Time?
Schmeltzer, P. A., & Talwalkar, J. A. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2011.06.010 · Cited by 50
Multilayered Heparin Hydrogel Microwells for Cultivation of Primary Hepatocytes
You, J., Shin, D., Patel, D., Gao, Y., & Revzin, A. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300054 · Cited by 45
Nicotinic acid prevents experimental liver fibrosis by attenuating the prooxidant process
Arauz, J., Rivera‐Espinoza, Y., Shibayama, M., Favari, L., Flores‐Beltrán, R. E., & Muriel, P. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.045 · Cited by 45
Targeting 15d-Prostaglandin J2 to Hepatic Stellate Cells: Two Options Evaluated
Hagens, W. I., Mattos, A., Greupink, R., de Jager-Krikken, A., Reker-Smit, C., van Loenen-Weemaes, A., Gouw, A. S. H., Poelstra, K., & Beljaars, L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9175-2 · Cited by 44
Saile, B., Matthes, N., Neubauer, K., Eisenbach, C., El-Armouche, H., Dudás, J., & Ramadori, G. P. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00441.2001 · Cited by 44
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Chu, R., Wang, Y., Kong, J., Pan, T. S., Yang, Y., & He, J. F. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02766j · Cited by 51
Ohno, N., Terada, N., & Ohno, S. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0173-6 · Cited by 43
PI3K is involved in PDGF-β receptor upregulation post-PDGF-BB treatment in mouse HSC
Lechuga, C. G., Hernández-Nazara, Z. H., Hernández, E., Bustamante, M., Desierto, G., Cotty, A., Dharker, N., Choe, M., & Rojkind, M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2005 · Cited by 43
van Beuge, M. M., Prakash, J., Lacombe, M., Post, E., Reker‐Smit, C., Beljaars, L., & Poelstra, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0430-9 · Cited by 42
Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key
Bansal, M. B. (2016) · Hepatology International · doi:10.1007/s12072-016-9758-x · Cited by 46
Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis
Thomsen, K. L., Chiara, F. D., Rombouts, K., Vilstrup, H., Andreola, F., Mookerjee, R. P., & Jalan, R. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.02.010 · Cited by 43
The Serum Endothelın-1 Level in Steatosıs and NASH, and Its Relatıon wıth Severıty of Lıver Fıbrosıs
Değertekın, B., Özeni̇rler, S., Elbeğ, Ş., & Akyol, G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9147-8 · Cited by 42
No, D. Y., Jeong, G. S., & Lee, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.009 · Cited by 45
Karadeniz, G., Açıkgöz, Ş., Tekin, İ. Ö., Tascýlar, O., Gün, B. D., & Cömert, M. (2008) · Clinics · doi:10.1590/s1807-59322008000400020 · Cited by 41
Damba, T., Zhang, M., Buist‐Homan, M., van Goor, H., Faber, K. N., & Moshage, H. J. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.08.004 · Cited by 45
Suflețel, R. T., Melincovici, C. S., Gheban, B., Zaharie, T., & Mihu, C. M. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.01 · Cited by 46
Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis
Takahara, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i40.6473 · Cited by 41
Relationship between oxidative stress levels and activation state on a hepatic stellate cell line
Guimarães, E. L. M., Franceschi, M. F. S., Grivicich, I., Dal‐Pizzol, F., Moreira, J. C. F., Guaragna, R. M. V. D. C., Borojević, R., Margis, R., & Guma, F. T. C. R. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01245.x · Cited by 56
Adrian, J. E., Kamps, J. A. A. M., Scherphof, G. L., Meijer, D. K. F., van Loenen-Weemaes, A. M., Reker‐Smit, C., Terpstra, P., & Poelstra, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.027 · Cited by 44
Chen, P., Huang, C., Meng, X., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.016 · Cited by 44
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy
Omar, R., Yang, J., Liu, H., Davies, N. M., & Gong, Y. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2016_6 · Cited by 44
Key role of liver sinusoidal endothelial cells in liver fibrosis
Xu, M., Wang, X., Zou, Y., & Zhong, Y. (2017) · BioScience Trends · doi:10.5582/bst.2017.01007 · Cited by 45
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles
Lim, H. K., Jeffrey, G. P., Ramm, G. A., & Soekmadji, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587628 · Cited by 47
Ogawa, T., Tateno, C., Asahina, K., Fujii, H., Kawada, N., Obara, M., & Yoshizato, K. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0237-7 · Cited by 39
Hepatic stellate cells increase in Toxoplasma gondii infection in mice
Atmaca, H., Gazyağci, A. N., Canpolat, S., & Kul, O. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-135 · Cited by 37
Chen, J., Yang, Y.-J., Meng, X.-Y., Lin, R.-H., Tian, X.-Y., Zhang, Y., Lai, W., Yang, C., Ma, X., & Huang, M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155585 · Cited by 44
cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease
Elnagdy, M., Barve, S. S., McClain, C. J., & Gobejishvili, L. (2020) · Biomolecules · doi:10.3390/biom10101433 · Cited by 39
Miele, L., Forgione, A., Gasbarrini, A., & Grieco, A. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.011 · Cited by 39
Mekonnen, G. A., IJzer, J., & Nederbragt, H. (2007) · Veterinary Pathology · doi:10.1354/vp.44-6-803 · Cited by 39
Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components
Tokusashi, Y., Asai, K., Tamakawa, S., Yamamoto, M., Yoshie, M., Yaginuma, Y., Miyokawa, N., Aoki, T., Kino, S., Kasai, S., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20685 · Cited by 41
Makino, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i13.2053 · Cited by 37
Morphogens and hepatic stellate cell fate regulation in chronic liver disease
Tsukamoto, H., Zhu, N., Wang, J., Asahina, K., & Machida, K. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07022.x · Cited by 37
Liu, Y., Lui, E. L. H., Friedman, S. L., Li, L., Ye, T., Chen, Y., Poon, R. T. P., Wo, J. Y. H., Kok, T. W., & Fan, S. T. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.127 · Cited by 40
Tao, F., Sayo, K., Sugimoto, K., Aoki, S., & Kojima, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-63621-4 · Cited by 37
Elrick, L. J., Leel, V., Blaylock, M. G., Duncan, L., Drever, M. R., Strachan, G., Charlton, K. A., Koruth, M., Porter, A. J., & Wright, M. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.028 · Cited by 37
Liver cirrhosis and hepatic stellate cells
Brandão, D. F., Ramalho, L. N. Z., Ramalho, F. S., Zucoloto, S., Martinelli, A. D. L. C., & Silva, O. D. C. E. (2006) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502006000700013 · Cited by 37
Bone marrow-derived fibrocytes contribute to liver fibrosis
Xu, J., & Kisseleva, T. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584933 · Cited by 37
The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: A concise review
Kim, J., & Kim, Y. J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122547 · Cited by 43
Metadata
- Authors
- Geerts, A.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Geerts, Albert
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 21
- Issue
- 03
- Pages
- 311-336
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2016498524
- Cited by
- 740
- References
- 0
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 32 · 2023: 20 · 2022: 36 · 2021: 28 · 2020: 35 · 2019: 28 · 2018: 28 · 2017: 33 · 2016: 37 · 2015: 50 · 2014: 30 · 2013: 40 · 2012: 33
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Northwest Fisheries Science Center
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- hepatic stellate cells, liver histopathology, vitamin A storage, extracellular matrix turnover, matrix metalloproteinases, liver fibrosis, space of Disse, sinusoidal blood flow, paracrine signaling, liver homeostasis
- MeSH terms
- Cell Communication, Chemotactic Factors, Extracellular Matrix, Homeostasis, Humans, Hypertension, Portal, Liver, Liver Cirrhosis, Liver Neoplasms, Regional Blood Flow, Retinoids, Vitamin A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.